Skip to main content

Nasal Airway Obstruction

0
Pipeline Programs
2
Companies
10
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Aerin Medical
Aerin MedicalCA - Mountain View
3 programs
InFlux SystemN/A1 trial
Nasal Airway Obstruction Surgical InterventionsN/A
VivaerN/A5 trials
Active Trials
NCT01960816Completed33Est. Apr 2016
NCT06922955Active Not Recruiting400Est. Dec 2027
NCT05099263Completed70Est. Oct 2024
+3 more trials
Medtronic
MedtronicNJ - Phillipsburg
1 program
Novapak Nasal Sinus Packing and StentN/A1 trial
Active Trials
NCT05747014Completed86Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Aerin MedicalVivaer
MedtronicNovapak Nasal Sinus Packing and Stent
Aerin MedicalVivaer
Aerin MedicalVivaer
Aerin MedicalVivaer
Aerin MedicalVivaer
Aerin MedicalVivaer
Aerin MedicalVivaer
Aerin MedicalVivaer
Aerin MedicalInFlux System

Clinical Trials (10)

Total enrollment: 1,057 patients across 10 trials

NCT06922955Aerin MedicalVivaer

A Prospective Study Comparing VivAer to Alternative Surgical Procedures to Treat Nasal Airway Obstruction in Patients With Nasal Valve Dysfunction.

Start: Feb 2025Est. completion: Dec 2027400 patients
N/AActive Not Recruiting
NCT05747014MedtronicNovapak Nasal Sinus Packing and Stent

Novapak Prospective Observational Clinical Trial

Start: Mar 2023Est. completion: Dec 202386 patients
N/ACompleted
NCT05099263Aerin MedicalVivaer

The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)

Start: Sep 2021Est. completion: Oct 202470 patients
N/ACompleted
NCT04717791Aerin MedicalVivaer

Evaluate the Effectiveness of the Vivaer ARC Stylus for Nasal Breathing

Start: Sep 2020Est. completion: Oct 2022118 patients
N/ACompleted
NCT04549545Aerin MedicalVivaer

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

Start: Aug 2020Est. completion: Mar 2025119 patients
N/ACompleted
NCT04277507Aerin MedicalVivaer

Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction

Start: Feb 2020Est. completion: Oct 2024122 patients
N/ACompleted
NCT03290300Aerin MedicalVivaer

Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device

Start: Oct 2017Est. completion: Jul 202239 patients
N/ACompleted
NCT03156270Aerin MedicalVivaer

Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction

Start: Sep 2017Est. completion: Aug 201920 patients
N/ACompleted
NCT02914236Aerin MedicalVivaer

Treatment of Nasal Airway Obstruction Using the Aerin Medical Device

Start: Sep 2016Est. completion: Aug 201750 patients
N/ACompleted
NCT01960816Aerin MedicalInFlux System

InFlux System for Nasal Breathing Improvement

Start: Sep 2013Est. completion: Apr 201633 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.